|
- Rules | The Nasdaq Stock Market
(b) Securities qualified for listing under this IM-5505-1 must begin trading on Nasdaq following the initial pricing through the mechanism outlined in Rule 4120 (c) (8) and Rule 4753
- Public Company Alert 11. 21 - honigman. com
If the disclosed amount of stockholders’ equity is less than $2 5 million and the company also fails to meet the Nasdaq Listing Rule 5550(b)’s market value standard and net income standard, then Nasdaq will deliver a notice of deficiency to the company
- Agile Therapeutics Regains Compliance With Nasdaq Minimum
Nasdaq Listing Rule 5550 (b) (1) requires companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,5000,000 (the “Stockholders’ Equity Requirement”)
- Allarity Therapeutics Receives Extension from Nasdaq Hearings . . .
To ensure compliance with the rules of The Nasdaq Capital Market (“Nasdaq”) by April 24, 2024, or sooner, the Company is working towards achieving a stockholders’ equity of at least $2 5 million and a minimum bid price of $1 00 per share or more for a minimum of 10 consecutive business days
- Asset Entities Inc. Regains Compliance with Nasdaq Listing . . .
On August 21, 2024, the Staff notified the Company that it did not comply with the minimum $2 5 million stockholders’ equity requirement for companies listed on The Nasdaq Capital Market under
- Nasdaq Changes Rules Regarding Minimum Bid Price Compliance . . .
The Securities and Exchange Commission (SEC) recently approved rule changes proposed by The Nasdaq Stock Market LLC that impact companies utilizing reverse stock splits to regain compliance with Nasdaq’s minimum bid-price requirement for continued listings
- EzFill regains compliance with Nasdaq listing standard
EzFill Holdings has regained compliance with Listing Rule 5550 (b) (1) which requires a minimum stockholders’ equity of $2,500,000
|
|
|